BioLight Life Sciences (BioLight Life Sciences) Total Assets : $8.74 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is BioLight Life Sciences Total Assets?

BioLight Life Sciences's Total Assets for the quarter that ended in Dec. 2023 was $8.74 Mil.

During the past 12 months, BioLight Life Sciences's average Total Assets Growth Rate was -37.00% per year. During the past 3 years, the average Total Assets Growth Rate was 18.60% per year. During the past 5 years, the average Total Assets Growth Rate was -6.80% per year. During the past 10 years, the average Total Assets Growth Rate was 11.50% per year.

During the past 12 years, BioLight Life Sciences's highest 3-Year average Total Assets Growth Rate was 59.10%. The lowest was -15.70%. And the median was 9.05%.

Total Assets is connected with ROA %. BioLight Life Sciences's annualized ROA % for the quarter that ended in Dec. 2023 was -22.02%. Total Assets is also linked to Revenue through Asset Turnover. BioLight Life Sciences's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

BioLight Life Sciences Total Assets Historical Data

The historical data trend for BioLight Life Sciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences Total Assets Chart

BioLight Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

19.58

16.94

16.76

14.89

8.74

BioLight Life Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial															16.76	17.24	14.89	24.44	8.74

BioLight Life Sciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

BioLight Life Sciences's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	7.916	+	0.823
	=	8.74

BioLight Life Sciences's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	7.916	+	0.823
	=	8.74

BioLight Life Sciences (NAS:BOLT) Total Assets Explanation

Total Assets is connected with ROA %.

BioLight Life Sciences's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-3.654	/	( (24.444	+	8.739)	/ 2 )
	=	-3.654	/	16.5915
	=	-22.02 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

BioLight Life Sciences's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0.022	/	( (24.444	+	8.739)	/ 2 )
=	0.022	/	16.5915
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

BioLight Life Sciences Total Assets Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLight Life Sciences (BioLight Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (NAS:BOLT) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

BOLT:Israel

Address

Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101

Website

http://www.bio-light.co.il

BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.